Halaman 4 - Kanker pankreas Dokter Terbaik - TOP-128 dokter

Prof. Klaus Kaczirek adalah ahli bedah endokrin dan onkologi terkemuka, spesialis dalam tumor neuroendokrin di Wiener Privatklinik.

• Lebih dari 30 tahun pengalaman dalam bedah endokrin
• Profesor Bedah di Medical University of Vienna
• Banyak mempublikasikan karya ilmiah tentang biologi tumor endokrin dan bedah invasif minimal
• Wakil Kepala Departemen Bedah Umum di Vienna General Hospital

Dr. Hossein Taghizadeh berspesialisasi dalam kanker pankreas dan empedu, mengintegrasikan terapi sistemik modern dengan perawatan pribadi di Wiener Privatklinik.

• Menempuh pendidikan di Universitas Kedokteran Wina – salah satu sekolah kedokteran terkemuka di Austria
• Ahli dalam kemoterapi, terapi target, dan imunoterapi untuk tumor gastrointestinal
• Berfokus pada pengobatan berbasis bukti dan dukungan pasien secara holistik
• Bekerja dengan alat diagnostik canggih untuk perencanaan perawatan yang tepat

Prof. Dr. med. Karl J. Oldhafer adalah pakar terkemuka dalam bedah kanker pankreas, hati, dan lambung di Rumah Sakit Asklepios Barmbek.

• Konsultan Senior Bedah Umum dan Abdomen serta Onkologi Bedah
• Memimpin Pusat Penyakit Hati yang berspesialisasi dalam bedah hati kompleks
• Menggunakan teknik mutakhir seperti bedah hati dengan navigasi komputer
• Bekerja dengan tim multidisiplin termasuk spesialis onkologi dan radiologi
• Berspesialisasi dalam teknik bedah abdomen invasif minimal

Associate Professor Tahsin Ozatli berspesialisasi dalam mengobati kanker payudara, paru-paru, dan gastrointestinal di Rumah Sakit Universitas Istinye Liv.

• Pengalaman dari berbagai klinik onkologi termasuk rumah sakit pemerintah dan pusat penelitian
• Dipromosikan menjadi Associate Professor pada tahun 2016
• Menempuh pendidikan kedokteran di Universitas Selcuk di Konya, Turki

Terlatih dalam bedah laparoskopi tingkat lanjut dan bariatrik di Universitas Istanbul – pemimpin dalam teknik invasif minimal untuk kanker pankreas.

• Spesialisasi dalam bedah laparoskopi sejak 2002
• Pelatihan lanjutan dalam bedah bariatrik laparoskopi dan onkologi kanker
• Pendidikan dari institusi medis terkemuka di Turki termasuk Universitas Istanbul

Profesor Gul Alco berspesialisasi dalam onkologi radiasi untuk kanker pankreas di Universitas Medipol Istanbul.

• Pengalaman lebih dari 20 tahun di bidang onkologi radiasi
• Berspesialisasi dalam pengobatan kanker pankreas
• Associate Professor dan kemudian Profesor di Universitas Demiroglu Bilim
• Pelatihan ekstensif di bidang onkologi radiasi

Assoc. Prof. Nail Paksoy berspesialisasi dalam pengobatan kanker pankreas di Rumah Sakit Medipol Bahçelievler, didukung oleh penelitian mendalam dan uji klinis.

• Sertifikasi Dewan ESMO dalam Onkologi Medis
• Sub-investigator dalam uji klinis kanker pankreas, termasuk RECITE – AMGEN
• Penelitian yang dipublikasikan mengenai FOLFIRINOX vs Gemcitabine + Nab-Paclitaxel pada Kanker Pankreas
• Pelatihan fellowship di Institut Onkologi Universitas Istanbul

Spesialis dalam viroterapi – salah satu bidang imunologi terbaru – Dr. Jaunalksne membawa 30+ tahun pengalaman dalam pengobatan kanker pankreas.

• Memimpin Pusat Imunologi Klinis di Rumah Sakit Universitas Klinis Pauls Stradins
• Lulus dari Institut Medis Riga dengan magang di Penyakit Dalam
• Berfokus pada pendekatan imunologi inovatif untuk kanker

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Spesialis dalam kanker pankreas di Medical Park Antalya, menempuh pendidikan di program onkologi medis bergengsi di Universitas Akdeniz.

• Menyelesaikan spesialisasi onkologi medis pada tahun 2018
• Bekerja di kompleks rumah sakit Medical Park terkemuka di Antalya
• Lebih dari 16 tahun pengalaman medis
• Peran sebelumnya di rumah sakit pendidikan universitas

Dr. Ozden membawa lebih dari 20 tahun pengalaman medis, berspesialisasi dalam pengobatan kanker pankreas di Rumah Sakit VM Medical Park Pendik.

• Lulus dari Fakultas Kedokteran Cerrahpaşa yang bergengsi di Universitas Istanbul
• Menyelesaikan subspesialisasi Onkologi Medis di Universitas Kocaeli
• Memiliki pengalaman luas dalam penyakit dalam sebelum berspesialisasi dalam onkologi

Dr. Auala Hubert adalah Kepala Pusat Kanker Gastrointestinal di Hadassah Medical Center – seorang ahli yang berfokus pada pengobatan kanker sistem pencernaan, termasuk kanker pankreas.

• 33 tahun pengalaman spesialis dalam onkologi dan radioterapi
• Memimpin pusat kanker multidisiplin di rumah sakit universitas ternama
• Sertifikasi dewan medik dalam onkologi medis dan radioterapi
• Anggota aktif Komite Nasional untuk Kanker Gastrointestinal
• Memiliki gelar ganda dalam kedokteran dan psikologi

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.